Clinical Trial Update: Adrenal Suppression and Absorption Study of Halobetasol Propionate Foam in Subjects 12-17 With Plaque Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 trial updating Adrenal suppression and absorption of halobetasol propionate foam in adolescents with plaque psoriasis; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Halobetasol propionate foam (halobetasol propionate)

Snippet

Sponsor: Mayne Pharma International Pty Ltd | Conditions: Plaque Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2023-07-06